Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Baird has initiated coverage of EquipmentShare.com (NASDAQ: EQPT) with an Outperform rating and a $63 price target, implying roughly 86% upside from the current share price of $33.77. The firm highlighted the company’s capital-light growth model, the T3 technology platform and plans to expand 70-80 branches annually through 2030. Recent market acti…
The U.S. dollar nudged higher Tuesday as U.S. markets reopened after a holiday, with investors positioning ahead of a string of domestic economic releases including Federal Reserve minutes and the PCE price index. Sterling fell after U.K. labor-market data showed rising unemployment and slowing pay growth. Other currencies saw muted moves as Asian …
Theon shares climbed more than 3% on Tuesday after the company released preliminary 2025 results that topped analyst projections across key metrics. The firm reported a €1.4 billion soft order backlog, sales of €444 million, an adjusted EBIT margin of 26.2%, and year-end net cash of €126.9 million. Management expects 2026 revenues of €570-600 milli…
Raymond James moved Marsh (NYSE: MRSH) from Outperform to Strong Buy while trimming its price target to $225 from $240, arguing the stock is experiencing a valuation reset rather than a deterioration in near-term fundamentals. The firm pointed to Marsh’s resilient earnings profile, margin expansion track record, and the strongest credit signal amon…
Rothschild Redburn lowered its rating on Warner Bros. Discovery to Neutral from Buy and lifted its price target to $31.00 from $28.00, citing Netflix as the most probable buyer and limited likelihood of significantly higher offers from Paramount. The firm pegs the remaining Discovery Global unit at $2.80 per WBD share and applies a 4.5x EBITDA mult…
Norma Group met its full-year 2025 guidance after reporting Q4 results slightly above consensus and completing the sale of its Water Management business. Sales and adjusted EBIT margin outperformed forecasts, while cash flow strengthened. The company plans to deploy €650 million in net proceeds to lower leverage, reinforce its core operations and r…
Agility Global reported fourth-quarter 2025 results that outperformed consensus, with revenue rising to $1.42 billion and headline profitability lifted by substantial one-off gains. While statutory EBITDA and net income far exceeded analyst expectations, adjusted results excluding one-time items were more modest and missed some sell-side forecasts.
Rothschild Redburn reduced its rating on ICON plc to Neutral from Buy and cut its price target to $100 from $226 after the company disclosed an internal accounting investigation into revenue recognition covering fiscal years 2023 through 2025. Preliminary findings indicate potential overstatements of under 2% for each of fiscal 2023 and 2024; ICON …
Baird has begun formal coverage of Tempus AI Inc (NASDAQ:TEM), assigning an Outperform rating with a $59.00 price objective, roughly 14% above the current share price of $51.95. The research note accompanies a Speculative Risk designation and comes as Tempus reports preliminary, unaudited commercial milestones including a record total contract valu…
Baird has begun coverage of Guardant Health (NASDAQ: GH) with an Outperform rating and a $120 price target, implying roughly 14% upside from the prevailing share price. The firm attached a Speculative Risk designation to the call and highlighted Guardant’s position in therapy-selection testing and pipeline optionality, while noting concerns about S…
Baird has initiated coverage of Grail, Inc. (NASDAQ: GRAL) with an Outperform rating and a $113.00 price target, implying roughly 16% upside from the referenced share price of $97.50. The firm classified the stock as Speculative Risk and pointed to clinical and regulatory milestones - including an NHS-Galleri study readout and a possible FDA decisi…
European competition and digital regulators have opened a wide range of investigations and levied sizeable fines against leading technology companies. The cases cover alleged anticompetitive conduct in online advertising and app stores, breaches of new digital rules, questions over access to data for AI use, and content-related compliance under rec…
Citizens initiated coverage of Immutep Limited (NASDAQ: IMMP) with a Market Outperform rating and a $6 price target, pointing to substantial upside from the stock's recent price of $2.64. The analyst cited clinical data supporting efti's immunostimulatory activity, an ongoing Phase 3 NSCLC trial, and a solid cash position, while noting valuation an…
Governments and regulatory bodies across multiple continents have initiated investigations, orders and access restrictions in response to reports that Grok, the AI chatbot developed by xAI and hosted on X, can produce sexually explicit or manipulated images, including material involving minors. Actions range from formal probes and evidence-preserva…
Sveafastigheter delivered Q4 results largely in line with analyst expectations. Income from property management rose to SEK96 million, outpacing broker estimates, and net reinvestment value per share matched forecasts at SEK80.4. Cost of debt eased modestly and leverage remained comfortably below policy limits, but property revaluations were negati…
JPMorgan has begun coverage of Marqeta Inc. (MQ) with an Overweight rating and a $6.00 price target, signaling material upside from the stock's recent trading level. The firm highlights projected gross profit expansion and strength in buy now, pay later volume while acknowledging profitability challenges and customer concentration risks tied to Cas…
Compass Point upgraded Upstart Holdings Inc (UPST) from Sell to Neutral and lifted its price target to $30 from $20, aligning the target with the stock's recent trading level. The adjustment follows Upstart's fourth-quarter 2025 results and the company’s 2025-2028 guidance, which includes a roughly 35% revenue compound annual growth rate and a term…
UBS has raised its rating on SSP Group Plc. to Buy from Neutral and increased its price target to GBP2.45 from GBP1.80, flagging an improved outlook for cash generation and several potential upside catalysts alongside recently reported stronger financial results for the second half of 2025. The bank projects material free cash flow growth through 2…
UBS upgraded Southwest Airlines (LUV) to Buy from Neutral and raised its price target to $73 from $51, pointing to greater-than-anticipated revenue potential from extra-legroom seating, assigned seats, and checked-bag fees. The bank projects these initiatives could add roughly $4.25 to $4.50 in incremental EPS at full run-rate by fiscal 2027, and h…
The Spanish government has asked prosecutors to examine whether social media platforms X, Meta and TikTok have been used to create and disseminate child sexual abuse material generated with artificial intelligence, Prime Minister Pedro Sanchez said. The move fits into a broader European push to address abusive and potentially illegal uses of AI and…
Brookfield Corporation (BN) trades like a conglomerate with a complexity tax: a diversified asset platform that markets often misprice because of structure and span. At $47.77 the stock sits close to its 52-week high but offers a play for patient swing traders who believe ongoing fee growth and operating cashflow expansion will re-rate the multiple…
A monthly Bank of America survey of 190 asset managers finds growing conviction that fiscal stimulus in Germany is filtering into macro data and helping lift the regional growth outlook. Respondents expressed increased preference for German equities, greater optimism for European cyclicals and small caps, and concentrated sector overweights in heal…
Roth/MKM has initiated coverage of Karooooo Ltd. (NASDAQ: KARO) with a buy recommendation and a $62.00 price target. The brokerage sees the fleet management software provider sustaining mid-teens growth, supported by market share in South Africa, underpenetrated product lines such as AI cameras and tracking tags, and accelerating subscription metri…
Fincantieri has won a contract exceeding €4 billion from Norwegian Cruise Line Group to construct three next-generation cruise ships for its Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises brands. The order - announced Monday - represents about 40% of Fincantieri’s projected 2026 intake and is slated for delivery in 2036-2037. …
Jefferies has begun coverage of Foghorn Therapeutics Inc. (NASDAQ: FHTX) with a Buy rating and a $12.00 price target, down from an earlier $14.00. The company, trading near $5.55 with a market capitalization of about $325 million, is being watched for a mid-2026 phase 1 readout of its SMARCA2 inhibitor FHD-909. Multiple brokerages have issued or re…
